Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study.
Kato Y, Ikarashi D, Kikuchi D, Takayama M, Kanzaki S, Ito A, Tamura D, Matsuura T, Maekawa S, Kato R, Kanehira M, Takata R, Sugimura J, Obara W. Kato Y, et al. Among authors: kanehira m. J Int Med Res. 2021 Aug;49(8):3000605211037478. doi: 10.1177/03000605211037478. J Int Med Res. 2021. PMID: 34407681 Free PMC article.
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.
Takata R, Katagiri T, Kanehira M, Tsunoda T, Shuin T, Miki T, Namiki M, Kohri K, Matsushita Y, Fujioka T, Nakamura Y. Takata R, et al. Among authors: kanehira m. Clin Cancer Res. 2005 Apr 1;11(7):2625-36. doi: 10.1158/1078-0432.CCR-04-1988. Clin Cancer Res. 2005. PMID: 15814643 Clinical Trial.
Eight year experience with Studer ileal neobladder.
Obara W, Isurugi K, Kudo D, Takata R, Kato K, Kanehira M, Iwasaki K, Tanji S, Konda R, Fujioka T. Obara W, et al. Among authors: kanehira m. Jpn J Clin Oncol. 2006 Jul;36(7):418-24. doi: 10.1093/jjco/hyl047. Epub 2006 Jun 27. Jpn J Clin Oncol. 2006. PMID: 16803843
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.
Obara W, Karashima T, Takeda K, Kato R, Kato Y, Kanehira M, Takata R, Inoue K, Katagiri T, Shuin T, Nakamura Y, Fujioka T. Obara W, et al. Among authors: kanehira m. Cancer Immunol Immunother. 2017 Jan;66(1):17-24. doi: 10.1007/s00262-016-1915-5. Epub 2016 Oct 18. Cancer Immunol Immunother. 2017. PMID: 27757561 Free PMC article. Clinical Trial.
129 results